Longevity Investor Network Member Spotlight: Sebastian Aguiar
Sebastian Aguiar, a member of the Longevity Investor Network, discusses biotechnology’s rejuvenation and the need to bridge the gap between R&D and research.
Sebastian Aguiar, a Venture Fellow with Apollo Ventures is an investor and company builder who focuses on the aging market. He invests in Europe and America. He can be found at https://www.linkedin.com/in/sebastianaguiar/ and https://twitter.com/sebastian_gero.
What first attracted you towards aging as a discipline in general?
Cells have already solved the problem of aging. The germline is immortal. Cancer cells are also immortal. Cellular immortality is a problem that has been solved for over 3.5 billions years, ever since life began on Earth. The soma, which is all cells except the reproductive ones, are thrown away.